MRI-based Robotic SBRT Microboost with Nodal Irradiation in Treatment of Aggressive Prostate Cancer
Jonathan W. Lischalk et al. | Abstract 2015 | ESTRO | 2024
Toxicity and Risk of Induced Second Cancer in the Treatment of Prostate Cancer using VMAT and 3D-CRT
Cheikh Tayeb et al. | Abstract 2094 | ESTRO | 2024
Clinical Introduction of a Real-time MLC-tracking System for Lung and Prostate Motion
André Haraldsson et al. | Abstract 1200 | ESTRO | 2024
Radiation-related Lymphopenia Post Prostate Stereotactic Body Radiation Therapy ± Pelvic Irradiation
Kelly Gaudian et al. | Abstract 1368 | ESTRO | 2024
Evaluation of Intrafractional Movements for Brain and Prostate SBRT Treatments with CyberKnife
Gábor Stelczer et al. | Abstract 2291 | ESTRO | 2024
The UPRATE trial: Feasibility of Seminal Vesicle PTV-margin Reduction with Online Adaptive SBRT
Victor J. Brand et al. | Abstract 2416 | ESTRO | 2024
Acute Toxicity from PACE-C Comparing Stereotactic Body Radiotherapy (SBRT) with Moderate Hypofractionation (MHRT)
Alison Tree et al. | Abstract 3395 | ESTRO | 2024
Independent Validation of Real-time Prostate Localization for MLC Tracking in Phantoms and Patients
Klara Stefansson et al. | Abstract 757 | ESTRO | 2024
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, Luke Nicholls, Daniel Henderson, Caroline Jones, Kirsty Morrison | Abstract 491 | ESTRO | 2024
Health-Related Quality of Life Following Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer
Vaibhav Sharma et al. | RSS | 2024
Acute Toxicity Following PSMA-Directed Focal Salvage Robotic SBRT for Local Recurrences Following Prior Robotic Prostate SBRT
Zachary Wilson et al | RSS | 2024
Moderately Hypofractionated Helical TomoTherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
Cozzi S, Ruggieri MP, Alì E, Ghersi SF, Vigo F, Augugliaro M, Giaccherini L, Iori F, Najafi M, Bardoscia L, Botti A, Trojani V, Ciammella P, Iotti C | In Vivo | 2023
Salvage Stereotactic Reirradiation for Intraprostatic Cancer Recurrence: A Large Retrospective Study
Allali S, Loap P, Bibault JE, Krepps S, Deforge A, Moreau D, Durdux C, Giraud P | Prostate | 2023
Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultra-hypofractionated Stereotactic Body Radiotherapy
Piotr Milecki, Anna Adamska, Anna Rucinska, Grzegorz Pałucki, Agnieszka Szumiło, Agnieszka Skrobała, Agata Jodda, Michał Michalak | J Pers Med | 2023
Stereotactic Body Radiation Therapy for Prostate Cancer: A Study Comparing 3-year Genitourinary Toxicity Between CyberKnife and Volumetric-Modulated Arc Therapy by Propensity Score Analysis
Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda, Kojiro Suzuki | Radiat Oncol | 2023
Robotic Stereotactic Body Radiotherapy for Localized Prostate Cancer: Final Analysis of the German Hypostat Trial
David Krug, Detlef Imhoff, Alfred Haidenberger, Nicole Heßler, Jane Schäfer, Stefan Huttenlocher, Georgios Chatzikonstantinou, Christoph Fürweger, Ulla Ramm, Inke R König, Felix Chun, Michael Staehler, Claus Rödel, Alexander Muacevic, Reinhard Vonthein, Jürgen Dunst, Oliver Blanck | Strahlenther Onkol | 2023
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
Tomita N, Soga N, Ogura Y, Hayashi N, Kageyama T, Ito M, Koide Y, Yoshida M, Kimura K, Makita C, Tachibana H, Kodaira T | J Cancer Res Clin Oncol | 2016
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell’Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C | Clin Oncol | 2016
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
Yamazaki H, Masui K, Suzuki G, Nakamura S, Shimizu D, Nishikawa T, Okabe H, Yoshida K, Kotsuma T, Tanaka E, Otani K, Yoshioka Y, Ogawa K | Cancers (Basel) | 2018
